Event JSON
{
"id": "eeb168285075b4593161fef11bd0f6662b1bf2dbcb290cd01fae3be85c53deca",
"pubkey": "a7973ec5129a8bc7dd08825f662ab9a03318538b0ea204338b4a7ea686150246",
"created_at": 1726492972,
"kind": 1,
"tags": [
[
"d",
"89029d88-daf6-4971-a5e2-b070ce2b5051"
],
[
"subject",
"Drugmakers bet billions that targeted radiation could become the next cancer breakthrough"
],
[
"r",
"https://www.cnbc.com/2024/09/16/radiopharmaceuticals-race-heats-up-as-drugmakers-chase-novartis.html"
],
[
"snaid",
"6edd3227-e00c-4e68-bc80-50c832580e7f"
],
[
"published_at",
"1726492960"
],
[
"p",
"a7973ec5129a8bc7dd08825f662ab9a03318538b0ea204338b4a7ea686150246"
],
[
"imeta",
"url https://image.cnbcfm.com/api/v1/image/108034530-1726488992991-gettyimages-149126447-70683282.jpeg?v=1726489029\u0026w=1920\u0026h=1080",
"alt Article image"
],
[
"p",
"5f7bc57f61a88f5c2728ac4576686198b2d761785d46ca59bb9af4ac31f59f91"
]
],
"content": "Drugmakers bet billions that targeted radiation could become the next cancer breakthrough\nhttps://image.cnbcfm.com/api/v1/image/108034530-1726488992991-gettyimages-149126447-70683282.jpeg?v=1726489029\u0026w=1920\u0026h=1080\n\nBristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind Novartis' Pluvicto.\n\nhttps://www.cnbc.com/2024/09/16/radiopharmaceuticals-race-heats-up-as-drugmakers-chase-novartis.html",
"sig": "23ad029cbf2a905bac43f70e2169d200b1ad4f96d89cf961845b2b3749a0bac793c554aa545610998b01e1c49044c2fb026f720c1e3c20ac3dd97a0b1f0ffe59"
}
